Actinobac Biomed's Grant

Actinobac Biomed raised a round of funding on March 28, 2013. Investors include National Institutes of Health.

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon…

Articles about Actinobac Biomed's Grant: